NCPI Workmark
Articles in regional publications that pertain to a wide range of North Carolina-related topics.

Search Results


19 results for Biotechnology
Currently viewing results 16 - 19
Previous
PAGE OF 2
Record #:
10940
Author(s):
Abstract:
The Research Triangle forged the state's reputation as a biotechnology power. Murray, managing editor of BUSINESS NORTH CAROLINA, discusses with leaders of the North Carolina Biotechnology Center the efforts of the industry to extend the sector to other sections of the state. The center is a nonprofit that promotes biotechnology and lobbies on its behalf.
Source:
Subject(s):
Record #:
24192
Author(s):
Abstract:
Floyd Chilton discusses his business, Pilot Therapeutics Inc., and the difficulty he had with running a business on his own.
Record #:
8008
Author(s):
Abstract:
A panel of life-sciences experts--Don deBethizy, CEO of Targacept, Inc., a Winston-Salem company developing treatments for central nervous system disorders; Jan Turek, CEO of Biolex Therapeutics, Inc., a Pittsboro drug-maker; Jeff Clark, managing general partner of the Aurora Funds, a Durham venture-capital company; Robert McMahan, Gov. Michael Easley�s science adviser; and Sam Taylor, president of the North Carolina Biosciences Organization, a trade group based in the Research Triangle Park--discuss the state of biomanufacturing in North Carolina, whether the state can compete in this market, and the new North Carolina Research Campus being built in Kannapolis.
Source:
Subject(s):
Full Text:
Record #:
36285
Author(s):
Abstract:
North Carolina’s contribution to industries such as biotechnology and its quality of life may define it as a wonderful place to live and work. Supporting this belief were six experts, offering insights about its place in the biotech global market, the importance of industry in the state, appeals the area has to international biotech companies, the importance of workforce training to international biotech companies, and what will keep such companies in North Carolina.